Table 2.

Characterization of opinions towards AAP probiotic statement and an FDA-approved probiotic formulation.

Survey questions	n (%)
Impact of AAP probiotics statement on provider stance on probiotic use	n = 406
Yes	184 (45.3%)
No	222 (54.7%)
Importance of an FDA-approved probiotic formulation for administration
Very important	211 (52.0%)
Somewhat important	133 (32.8%)
Neutral	50 (12.3%)
Not important	12 (3.0%)
Influence of an FDA-approved probiotic formulation for administration
Yes	290 (71.4%)
No	35 (8.6%)
Already routinely administer probiotics	81 (20.0%)
Willingness to institute a new FDA-approved probiotic if it decreased the incidence of NEC by as little as:
10%	102 (25.1%)
25%	129 (31.8%)
50%	62 (15.3%)
75%	8 (2.0%)
>75%	31 (7.6%)
Already routinely administer probiotics	74 (18.2%)